Immediate Impact
31 standout
Citing Papers
The prospect of artificial intelligence to personalize assisted reproductive technology
2024 Standout
Reactive oxygen species and ovarian diseases: Antioxidant strategies
2023 Standout
Works of Joan Schertz being referenced
Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joan Schertz | 387 | 330 | 159 | 24 | 413 | |
| Melanie Walls | 334 | 340 | 137 | 17 | 431 | |
| A. Zapantis | 374 | 254 | 177 | 17 | 447 | |
| M. Cohen-Bacrie | 330 | 211 | 98 | 12 | 386 | |
| Oybek Rustamov | 374 | 298 | 106 | 12 | 390 | |
| M. Brassesco | 345 | 265 | 120 | 16 | 447 | |
| Helene Westring Hvidman | 332 | 209 | 133 | 18 | 383 | |
| E. Schoute | 295 | 299 | 184 | 19 | 481 | |
| Mauro Schimberni | 314 | 289 | 222 | 22 | 471 | |
| Arnaud Reignier | 212 | 295 | 196 | 43 | 394 | |
| Clare Boothroyd | 334 | 229 | 111 | 18 | 491 |
All Works
Loading papers...